UNAM researchers supported to publish open access articles in over 2,400 Taylor & Francis journals

Three-year OA agreement aims to boost the global reach and impact of Universidad Nacional Autónoma de México research

2025-05-22

(Press-News.org) The global impact of Universidad Nacional Autónoma de México (UNAM) research is set to increase under a new open access (OA) agreement with publisher Taylor & Francis. The three-year partnership will enable UNAM researchers to publish OA articles in more than 2,400 journals.

OA publishing supports UNAM's ambition to be a leading international hub of excellence in research and innovation, through fostering collaboration and ensuring the latest work can be freely accessed by researchers, policymakers, and practitioners worldwide.

Taylor & Francis’ first ‘read & publish’ agreement in Mexico maintains the academic community’s reading access to the full range journals and introduces a new route to open up the latest research. Articles published OA under the agreement in Taylor & Francis and Routledge Open Select (hybrid) and full open access journals will be immediately available to readers everywhere.

The agreement is expected to particularly benefit research in fields where there is otherwise limited funding for open access publishing charges.

Antonio Sánchez, from the General Directorate of Libraries and Digital Information Services (DGBSDI) at UNAM, said: “Through this agreement, our university seeks to support its researchers to exempt them from paying fees for open access publishing, as well as, more importantly, to broaden the national and international audience and impact of their scientific and cultural contribution”.

Jeff Voci, Senior Vice President & Commercial Lead – Americas at Taylor & Francis, added: “One of the oldest universities in the Americas, UNAM is a world-class research institution with impactful programs across diverse areas, from artificial intelligence and nanoscience to renewable energy and health. I’m delighted that our new OA partnership will enable much more of this vital work to be read and built upon by researchers around the globe.”

Taylor & Francis is a leading open research publisher, working with institutions, societies and consortia around the world to design solutions that achieve their open goals. UNAM joins over 1,000 institutions supporting their researchers to publish OA through a Taylor & Francis agreement, including more than 100 institutions in the Americas.

END

ELSE PRESS RELEASES FROM THIS DATE:

NIH scientists test in an animal model a surgical technique to improve cell therapy for dry AMD

2025-05-22

What: National Institutes of Health (NIH) scientists have developed a new surgical technique for implanting multiple tissue grafts in the eye's retina. The findings in animals may help advance treatment options for dry age-related macular degeneration (AMD), which is a leading cause of vision loss among older Americans. A report about the technique published today in JCI Insight. In diseases such as AMD, the light-sensitive retina tissue at the back of the eye degenerates. Scientists are testing therapies for restoring damaged retinas with grafts of tissue ...

Two-step method to prevent biofilm regrowth is a SLAM dunk

2025-05-22

Most people have encountered the black, grey, or pink stains of bacterial biofilms built up on the bathroom tiles or kitchen sink. Even with vigorous scrubbing and strong cleaning chemicals, this grime can be difficult to remove and often returns with vengeance. A new study, published in Chemical Engineering Journal, reports a novel, two-step method to effectively dismantle bacterial biofilms and prevent regrowth. “Biofilms are everywhere, from bathrooms to food factories,” said Hyunjoon Kong (M-CELS leader/EIRH/RBTE), a professor of chemical and biomolecular engineering. “Biofilms are also responsible for cross contamination ...

New study from Aarhus questions European precautionary measures on paternal use of valproate

2025-05-22

A new study from researchers at Aarhus University and Aarhus University Hospital found no increased risk of neurodevelopmental disorders in children whose fathers were treated with valproate during spermatogenesis. The results have just been published in JAMA Network Open and cast new light on the European Medicines Agency’s (EMA's) recent recommendation for precautionary measures. In January 2024, EMA recommended precautionary measures for treating male patients with valproate, based on ...

SwRI’s Robin Canup receives 2025 AAS DDA Dirk Brouwer Career Award

2025-05-22

SAN ANTONIO — May 22, 2025 — Southwest Research Institute’s Dr. Robin Canup has received the 2025 Dirk Brouwer Career Award from the American Astronomical Society’s Division on Dynamical Astronomy (AAS DDA). As the vice president of SwRI’s Solar System Science and Exploration Division in Boulder, Colorado, Canup leads a team of about 120 contributing to a wide variety of space programs. Canup is best known for studies concerning the formation of planets and their satellites, including research that demonstrated how the Earth-Moon system could have been produced from a giant impact ...

Excellence Strategy: University of Halle receives funding for a Cluster of Excellence for the first time

2025-05-22

The Martin Luther University Halle-Wittenberg (MLU) is one of the winners of the Excellence Strategy. MLU applied for the Cluster of Excellence "Center for Chiral Electronics" (CCE) together with the Freie Universität Berlin, the University of Regensburg and the Max Planck Institute of Microstructure Physics in Halle. The Cluster of Excellence will receive up to 64.5 million euros in funding from the German Research Foundation (DFG) and will start in January 2026. It will initially run for seven years. Research will focus on new concepts ...

New factor linked to heart failure

2025-05-22

When the workload on the heart increases, the ventricular wall may thicken too, known as cardiac hypertrophy. This is an adaptive response that reduces pressure on the heart and maintains the activity of this vital organ. It is often a reversible process that does not cause serious effects on the structure or function of the heart, but if the factor causing cardiac overload becomes chronic, it can lead to pathological hypertrophy with more serious effects (dilatation of the ventricular cavities, alterations in cardiac function, heart failure, etc.). People with diabetes — specially type 2 diabetes (DM2) — are at increased risk ...

Potential of phytomedicine in benefiting both long COVID and acute coronary syndromes

2025-05-22

Acute coronary syndrome (ACS) in patients with SARS-CoV-2 infection represents a critical intersection of viral-induced inflammation and cardiovascular pathology. This review explores the dual mechanisms driving SARS-CoV-2-associated ACS and evaluates emerging therapeutic strategies, including phytomedicine and nanotechnology, to address both viral and cardiovascular complications. SARS-CoV-2 and ACS Pathogenesis SARS-CoV-2 infection exacerbates ACS through systemic inflammation, endothelial dysfunction, and plaque destabilization. The virus triggers a cytokine storm, marked by elevated inflammatory ...

Sounding out coral larval settlements #ASA188

2025-05-22

NEW ORLEANS, May 22, 2025 – Coral reefs are vital to marine biodiversity, but their livelihood is under threat due to climate instability and the impacts of human activities. Rehabilitating marine environments requires innovative solutions. Océane Boulais, a doctoral student at the Scripps Institution of Oceanography, studies one of these potential solutions: the impacts of acoustics on coral larval recruitment and settlement. After spawning, coral larvae drift or swim through the water column, seeking suitable sites to find a home to attach to along the ocean floor. “Multiple chemical compounds have already been identified as ...

New golden standard for medicine safety during breastfeeding

2025-05-22

Women who choose to stop treatment during pregnancy and breastfeeding are putting their health at risk, and have to weigh their desire to have children and breastfeed against a risk that we know very little about. In two ongoing clinical trials, researchers establish a new standard for human lactation studies that includes sampling of breast milk and plasma from both mothers and breastfed infants. “The lack of scientific evidence is an ethical problem for women and doctors, considering that around 70 percent of women need to use medicines sometime during their pregnancy. In many cases, women are recommended ...

Infrared contact lenses allow people to see in the dark, even with their eyes closed

2025-05-22

Neuroscientists and materials scientists have created contact lenses that enable infrared vision in both humans and mice by converting infrared light into visible light. Unlike infrared night vision goggles, the contact lenses, described in the Cell Press journal Cell on May 22, do not require a power source—and they enable the wearer to perceive multiple infrared wavelengths. Because they’re transparent, users can see both infrared and visible light simultaneously, though infrared vision ...